TERT promoter mutation analysis for blood-based diagnosis and monitoring of gliomas

PURPOSE. Liquid biopsy offers a minimally invasive tool to diagnose and monitor the heterogeneous molecular landscape of tumors over time and therapy. Detection of TERT promoter mutations (C228T, C250T) in cfDNA has been successful for some systemic cancers but has yet to be demonstrated in gliomas,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cancer Res
Main Authors: Muralidharan, Koushik, Yekula, Anudeep, Small, Julia L., Rosh, Zachary S., Kang, Keiko M., Wang, Lan, Lau, Spencer, Zhang, Hui, Lee, Hakho, Bettegowda, Chetan, Chicoine, Michael R., Kalkanis, Steven N., Shankar, Ganesh M., Nahed, Brian V., Curry, William T., Jones, Pamela S., Cahill, Daniel P., Balaj, Leonora, Carter, Bob S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7785705/
https://ncbi.nlm.nih.gov/pubmed/33051308
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-20-3083
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados